157 related articles for article (PubMed ID: 35908170)
1. Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh.
Papri N; Doets AY; Mohammad QD; Endtz HP; Lingsma HF; Jacobs BC; Islam Z
Ann Clin Transl Neurol; 2022 Aug; 9(8):1264-1275. PubMed ID: 35908170
[TBL] [Abstract][Full Text] [Related]
2. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Doets AY; Lingsma HF; Walgaard C; Islam B; Papri N; Davidson A; Yamagishi Y; Kusunoki S; Dimachkie MM; Waheed W; Kolb N; Islam Z; Mohammad QD; Harbo T; Sindrup SH; Chavada G; Willison HJ; Casasnovas C; Bateman K; Miller JAL; van den Berg B; Verboon C; Roodbol J; Leonhard SE; Benedetti L; Kuwabara S; Van den Bergh P; Monges S; Marfia GA; Shahrizaila N; Galassi G; Péréon Y; Bürmann J; Kuitwaard K; Kleyweg RP; Marchesoni C; Sedano Tous MJ; Querol L; Illa I; Wang Y; Nobile-Orazio E; Rinaldi S; Schenone A; Pardo J; Vermeij FH; Lehmann HC; Granit V; Cavaletti G; Gutiérrez-Gutiérrez G; Barroso FA; Visser LH; Katzberg HD; Dardiotis E; Attarian S; van der Kooi AJ; Eftimov F; Wirtz PW; Samijn JPA; Gilhuis HJ; Hadden RDM; Holt JKL; Sheikh KA; Karafiath S; Vytopil M; Antonini G; Feasby TE; Faber CG; Gijsbers CJ; Busby M; Roberts RC; Silvestri NJ; Fazio R; van Dijk GW; Garssen MPJ; Straathof CSM; Gorson KC; Jacobs BC;
Neurology; 2022 Feb; 98(5):e518-e532. PubMed ID: 34937789
[TBL] [Abstract][Full Text] [Related]
3. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
[TBL] [Abstract][Full Text] [Related]
4. Construction and evaluation of a prognostic prediction model based on the mEGOS score for patients with Guillain-Barré syndrome.
Xue G; Zhang Y; Wang R; Yang Y; Wang H; Li J; He X; Zhang Q; Yang X
Front Neurol; 2023; 14():1303243. PubMed ID: 38099064
[TBL] [Abstract][Full Text] [Related]
5. Reliability and validity of prognostic indicators for Guillain-Barré syndrome in children.
Qinrong H; Yuxia C; Ling L; Huayu L; Lei X; Xiaoli L; Nong X
Dev Med Child Neurol; 2023 Apr; 65(4):563-570. PubMed ID: 36175376
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome from an emergency department view: how to better predict the outcome?
Covino M; Romozzi M; Simeoni B; Di Paolantonio A; Sabatelli M; Franceschi F; Luigetti M
Neurol Res; 2022 Nov; 44(11):964-968. PubMed ID: 35580194
[TBL] [Abstract][Full Text] [Related]
7. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome.
Yao J; Zhou R; Liu Y; Liu Y; Cao Q; Lu Z
Neurol Ther; 2023 Dec; 12(6):2121-2132. PubMed ID: 37792219
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome.
Yamagishi Y; Kuwahara M; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida KI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
J Neurol Neurosurg Psychiatry; 2020 Dec; 91(12):1339-1342. PubMed ID: 33041261
[TBL] [Abstract][Full Text] [Related]
9. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
Yamagishi Y; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida K; Ikeda SI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
J Peripher Nerv Syst; 2017 Dec; 22(4):433-439. PubMed ID: 28833828
[TBL] [Abstract][Full Text] [Related]
10. [The prognosis and prognostic factor of Guillain-Barré Syndrome].
Yamagishi Y; Kusunoki S
Rinsho Shinkeigaku; 2020 Apr; 60(4):247-252. PubMed ID: 32238748
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain-Barré Syndrome in Somalia: Case series.
Sidow NO; Hassan MS
Ann Med Surg (Lond); 2022 Dec; 84():104816. PubMed ID: 36536744
[TBL] [Abstract][Full Text] [Related]
12. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
[TBL] [Abstract][Full Text] [Related]
13. Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.
van Tilburg SJ; Teunissen CE; Maas CCHM; Thomma RCM; Walgaard C; Heijst H; Huizinga R; van Doorn PA; Jacobs BC
EBioMedicine; 2024 Apr; 102():105072. PubMed ID: 38518653
[TBL] [Abstract][Full Text] [Related]
14. International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.
Doets AY; Walgaard C; Lingsma HF; Islam B; Papri N; Yamagishi Y; Kusunoki S; Dimachkie MM; Waheed W; Kolb N; Gorson KC; Jacobs BC;
Ann Neurol; 2022 Apr; 91(4):521-531. PubMed ID: 35106830
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-lymphocyte ratio in Guillain-Barré syndrome: A prognostic biomarker of severe disease and mechanical ventilation in Bangladesh.
Jahan I; Ahmed R; Ahmed J; Khurshid S; Biswas PP; Upama IJ; Hamid Y; Papri N; Islam Z
J Peripher Nerv Syst; 2023 Mar; 28(1):47-57. PubMed ID: 36700342
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serological prognostic factors in childhood Guillain-Barré syndrome: A prospective cohort study in Bangladesh.
Hasan I; Papri N; Hayat S; Jahan I; Ara G; Islam B; Islam Z
J Peripher Nerv Syst; 2021 Mar; 26(1):83-89. PubMed ID: 33555098
[TBL] [Abstract][Full Text] [Related]
17. A clinical prognostic scoring system for Guillain-Barré syndrome.
van Koningsveld R; Steyerberg EW; Hughes RA; Swan AV; van Doorn PA; Jacobs BC
Lancet Neurol; 2007 Jul; 6(7):589-94. PubMed ID: 17537676
[TBL] [Abstract][Full Text] [Related]
18. Early recognition of poor prognosis in Guillain-Barre syndrome.
Walgaard C; Lingsma HF; Ruts L; van Doorn PA; Steyerberg EW; Jacobs BC
Neurology; 2011 Mar; 76(11):968-75. PubMed ID: 21403108
[TBL] [Abstract][Full Text] [Related]
19. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort.
López-Hernández JC; Galnares-Olalde JA; Jorge de Saráchaga A; Briseño-Godínez ME; Pérez-Valdez E; May-Mas RN; Arista-Ramírez JL; Bazán-Rodríguez L; León-Manriquez E; Burgos-Centeno J; Vargas-Cañas ES
Neurol Sci; 2022 Jun; 43(6):3923-3928. PubMed ID: 35067827
[TBL] [Abstract][Full Text] [Related]
20. Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil.
Dourado Júnior MET; Fernandes UT; Ramos ES; Vital ALF; Urbano JCC; Queiroz JW; Jeronimo SMB
Acta Neurol Scand; 2018 Nov; 138(5):459-462. PubMed ID: 30003535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
